
Most investors spend considerable effort deciding what to buy and almost none thinking about when to sell. Yet selling well is the harder discipline, and it is where many of the costliest mistakes are made.
There are three broad circumstances in which selling a share makes sense. First, when your original reason for owning the company no longer holds: the business has deteriorated, management has lost direction, or a competitor has fundamentally changed the playing field. Second, when your wider portfolio demands it: a single position has grown too large, your asset mix has drifted, or better opportunities exist elsewhere. Third, when your own life requires it: you need the money, your goals have shifted, or your time horizon has changed. Everything below unpacks these three categories, and just as importantly, covers the situations where selling feels right but almost certainly is not.
One point worth making at the outset: no holding exists in isolation. Every sell decision is also, implicitly, a decision about your wider portfolio. A share you would happily own in a well-diversified portfolio might need trimming if it has grown to represent 40% of your net worth. Selling because a company’s prospects have dimmed is one thing; selling because your own circumstances have changed is another entirely. Both are valid. The framework below covers each.
Every purchase should begin with a thesis: a clear reason why you believe this company is worth owning at this price. The thesis might be simple (“this is a high-quality business with reliable earnings, trading at a fair price”) or more specific (“the market is undervaluing the company’s new product line, and I expect revenue growth to accelerate over the next two to three years”).
If you cannot articulate why you bought a share, you have no framework for deciding whether to sell it. You are, in effect, flying without instruments.
The thesis is your anchor. When the share price falls 15% in a week, the first question is “Has anything changed about the reason I own this?” If the answer is no, the price movement is noise. If the answer is yes, the price movement may be signal. The distinction matters enormously.
A broken thesis is the clearest sell signal. Recognising the difference between a thesis breaking and a price dropping is the central discipline of selling well.
Revenue is declining for structural rather than cyclical reasons. Margins are compressing and management has no credible plan to reverse the trend. A new competitor has emerged with a demonstrably better product or a lower cost base. Regulation has permanently impaired the company’s ability to earn at the level it once did.
The key word is permanently. Every company hits rough patches. A single bad quarter does not break a thesis. But a sustained deterioration in competitive position, profitability, or addressable market is a different matter. Ask yourself: if I were analysing this company today for the first time, with no emotional attachment, would I buy it at the current price? If the answer is clearly no, the thesis is likely broken.
Consider a New Zealand investor who bought shares in an NZX-listed company five years ago because of its dominant market position, consistent dividend history, and limited domestic competition. Two years later, a regulatory change opens the sector to overseas entrants, margins begin to compress, and the dividend is cut for the first time in a decade. The share price has fallen, but the price is not the problem. The thesis is. The competitive advantage the investor originally bought no longer exists in the same form. Holding on in the hope of a rebound, without re-examining whether the original logic still applies, is where value is quietly destroyed.
Good businesses can be destroyed by poor leadership. Directors making value-destructive acquisitions, executives prioritising short-term metrics over long-term health, persistent failure to deliver on stated targets, high turnover among senior leadership, or personal conduct creating reputational risk for the company: any of these can erode the foundation on which your thesis rested.
Management quality is harder to quantify than revenue growth, but it matters as much. Capital allocation is a CEO’s most important job, and if the evidence suggests capital is being allocated poorly, the thesis deserves re-examination.
When a company agrees to be acquired, the share price typically moves close to the offer price. The remaining upside is usually limited to the spread between the current price and the offer price, less any risk the deal falls through. For most investors, this is a reasonable time to exit, particularly in an all-cash deal where there is little uncertainty about the value you will receive.
Scrip-based acquisitions, where you receive shares in the acquiring company, require more thought. You are effectively being handed a new investment. Does the acquiring company meet the criteria you would apply if buying from scratch?
Even when a company’s thesis remains intact, your portfolio may require adjustment. These are sensible responses to how the portfolio as a whole is positioned.
A winning position you never trim can quietly become your biggest risk. A share you bought at $10 is now $50. If it now represents 35% of your portfolio, you have a concentration problem regardless of how much you like the business. The risk is asymmetric: the upside of holding is incremental growth, but the downside of a single adverse event is severe damage to your net worth.
This is a pattern we see often among New Zealand investors. A long-term holding in a successful NZX-listed company performs well over many years, the investor develops an attachment to it, and the position gradually grows to dominate the portfolio. What was once prudent diversification becomes, through inaction, a concentrated bet. The company may still be excellent, but the portfolio is no longer balanced. Trimming a position is not the same as losing faith in it. You can still believe in a company and reduce your exposure to limit the damage a single adverse event could cause.
Over time, different parts of a portfolio grow at different rates. A portfolio originally split 70/30 between shares and bonds may drift to 85/15 after a strong run in equity markets. Periodic rebalancing, selling some of the asset class which has outperformed and reallocating to the one which has not, is a discipline which forces you to sell high and buy low, systematically.
As you approach a financial goal or move closer to retirement, your overall allocation may also need to shift toward lower-risk assets. This is a time-horizon-driven sell decision.
Every dollar sitting in one investment is a dollar not working elsewhere. If you identify an opportunity offering materially better risk-adjusted returns than a current holding, reallocating makes sense. This is how Morningstar frames selling: as a capital reallocation decision, not a closing trade. You are redeploying capital where you expect it to earn a better return.
The discipline required here is genuine comparison. What are the expected returns on the current holding? What are the expected returns on the alternative? What are the risks of each? Selling a 7% expected-return holding to buy a 15% expected-return opportunity is rational. Selling because you are bored is not.
A word of caution: most retail investors will find it difficult to estimate expected returns with any precision. If this kind of comparative analysis is unfamiliar territory, it is worth seeking professional advice rather than relying on instinct. The risk of misapplying this principle, selling a solid holding for a speculative one, is real.
Sometimes the reason to sell has nothing to do with the investment and everything to do with you.
You need the money. Your child is starting university, you are buying a home, a medical bill has arrived, or your circumstances have simply changed. One of the virtues of listed shares is liquidity: you can sell and access cash relatively quickly.
There is no shame in selling for personal reasons. The entire point of investing is to fund a life. If the money is needed and the alternative is debt or financial stress, selling is the right call.
Two caveats. First, consider whether the need is genuinely urgent. If you can meet the expense from cash savings or by adjusting spending over a few months, leaving the investment intact may serve you better in the long run. Second, think about which holding to sell. If you have multiple positions, selling the one with the weakest forward outlook, or the largest unrealised loss for tax purposes, may be more sensible than selling your best performer.
If you’re unsure whether what you’re seeing is a genuine thesis break or just short-term noise, a conversation with an adviser can help you separate the two. Get in touch.
This may be the most valuable section in the article. The biggest cost to long-term investors is not the occasional bad sale; it is the accumulation of premature sales driven by emotion rather than analysis.
Share prices fluctuate. A 10% or even 20% decline in a given year is usual for a quality company. If you bought a share because of its competitive position, earnings trajectory, and management quality, a short-term price decline driven by market sentiment tells you nothing about whether those factors have changed.
Selling solely because the price has fallen is the single most common mistake retail investors make. It locks in losses, eliminates the opportunity for recovery, and reinforces a pattern of buying high, when optimism is abundant, and selling low, when fear takes over.
In our work with New Zealand investors, we most often see selling mistakes occur at exactly this point: a strong company reports one disappointing quarter, the share price drops, and the investor sells before taking time to assess whether anything structural has changed. More often than not, the company recovers and the investor is left having crystallised a loss they did not need to take.
Selling because you believe the market is “about to crash” requires you to be right twice: once on the exit and once on the re-entry. The evidence overwhelmingly suggests even professional fund managers cannot do this consistently. For long-term investors, time in the market almost always beats timing the market.
Selling because everyone else appears to be selling is herd behaviour, and it reliably produces poor outcomes. Market panics are driven by collective fear. The investors who perform best over decades are typically those who resist the urge to act in concert with the crowd.
Your purchase price is psychologically important to you and economically irrelevant. The share does not know what you paid for it. The only question is: given the current price and the company’s forward prospects, would you buy today? If yes, hold. If no, sell. Whether you are sitting on a gain or a loss should not influence the decision, though it often does.
The sunk cost fallacy is especially dangerous here. Investors hold losing positions far too long because selling would mean “admitting” the loss, as if the loss does not already exist in their portfolio. It does. Selling simply moves it from unrealised to realised.
A share price sitting flat for a year or two is not a sell signal. It may simply reflect a market digesting a period of strong prior growth, or a company quietly reinvesting in its future. The best long-term investments often include extended periods of doing nothing interesting at all. Patience is not exciting, but it compounds.
Selling purely because a position has risen is not, by itself, rational. If the thesis is intact and the valuation is still reasonable, the fact a share has doubled since you bought it is a reason to be pleased, not a reason to sell. Let winners run. The cost of selling a great business too early, over a lifetime of investing, is substantial.
This does not mean you should never take profits. But the decision to do so should be anchored to valuation, portfolio balance, or a change in outlook, not simply to the fact the share has gone up.
Once you have decided to sell, a little mechanical discipline makes the process smoother.
Decide before you need to. The best time to set sell criteria is when you buy. Write down the conditions under which you would exit: a sustained revenue decline of more than a certain percentage, a change in management, a valuation above a specified level, or simply “when the money is needed for a house deposit in three years.” Having these in writing removes emotion from the moment of decision.
Consider selling in stages. You do not have to sell your entire position at once. Trimming allows you to reduce exposure while retaining some upside. If a share has grown to an uncomfortable weight in your portfolio, selling a portion addresses the concentration issue without requiring you to make a binary all-or-nothing call.
Know your order types. A market order sells at the best available price and executes quickly. A limit order lets you set a minimum price, with the trade only executing if the market reaches it. For most long-term investors selling a liquid stock, market orders during trading hours are sufficient. For less liquid positions or large trades, a limit order provides more control.
Think about what comes next. Selling creates cash. What will you do with it? Reinvest in another opportunity? Hold for a future goal? Pay down debt? Having an answer before you sell prevents the cash from sitting idle or being deployed impulsively into the next appealing headline.
New Zealand does not have a comprehensive capital gains tax, but not all share sales are tax-free. Inland Revenue applies an intent-based test: if you acquired shares with a dominant purpose of selling them for a profit, the gain on sale is taxable income. Shares acquired as part of a regular trading pattern or a profit-making scheme are also caught.
In practice, long-term investors who bought shares for income or genuine long-term growth, and who are not engaged in a pattern of frequent buying and selling, are generally not taxed on gains when they sell. But if your activity looks more like trading than investing, Inland Revenue may take a different view. The IRD’s guidance on share investments sets out the rules in detail.
If you hold foreign shares with a combined cost exceeding NZ$50,000, the foreign investment fund (FIF) rules may also apply. These rules can create a taxable income calculation regardless of whether you sell. The interaction between FIF obligations and a sell decision is worth discussing with your accountant or tax adviser before acting.
It is also worth noting the distinction between holding shares directly and holding them through a managed fund or PIE structure. If your shares are held within a portfolio investment entity, the tax treatment on exit may differ from selling a direct shareholding. Many New Zealand investors hold shares through platforms or managed accounts without fully appreciating this difference. If you are unsure which applies to you, check with your provider or adviser before selling.
Most wealth is not lost in what investors buy. It is lost in when and why they sell.
The investor who panic-sells after a sharp decline, only to watch the recovery from the sidelines. The investor who holds a broken thesis for years because selling feels like failure. The investor who never trims a winning position until concentration risk turns a portfolio setback into a financial crisis. These are the patterns which compound over a lifetime, and they are all avoidable with a clear framework and the willingness to follow it.
Buying is optimism. Selling is discipline. If you would like help building yours, or if you’re facing a sell decision right now and want a second opinion, our investment team would welcome the conversation. Get in touch.


